You are here

  • Home
  • Archive
  • Volume 26, Issue 7
  • BET 1. NEBULISED HYPERTONIC SALINE SIGNIFICANTLY DECREASES LENGTH OF HOSPITAL STAY AND REDUCES SYMPTOMS IN CHILDREN WITH BRONCHIOLITIS

Article Text

Article menu
Download PDFPDF
Best Evidence Topic reports
BET 1. NEBULISED HYPERTONIC SALINE SIGNIFICANTLY DECREASES LENGTH OF HOSPITAL STAY AND REDUCES SYMPTOMS IN CHILDREN WITH BRONCHIOLITIS

http://dx.doi.org/10.1136/emj.2009.076208

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Report by: Daniel Horner, ST3 Emergency Medicine/Critical Care

    Search checked by: Rachel Jenner, Paediatric Emergency Medicine Consultant

    Institution: Booth Hall Childrens Hospital, Manchester, UK

    A short-cut review was carried out to establish whether nebulised hypertonic saline reduces length of stay and symptoms in children with bronchiolitis. One Cochrane review was found, which addressed this question. This review is summarised. The clinical bottom line is that nebulised hypertonic saline does reduce length of stay and symptoms in children with bronchiolitis.

    THREE-PART QUESTION

    In [children <2yrs with acute viral bronchiolitis] does [regular administration of nebulised hypertonic saline] lead to reduction in [mortality/morbidity rates or length of hospital stay]

    CLINICAL SCENARIO

    A 3-month-old books in to the emergency department with a 4-day history of a coryzal illness followed by breathing difficulties and decreased oral intake. It is December. Inwardly, you sigh …

    View Full Text